Crouse Steven C. has filed 7 insider transactions across 2 companies since April 2025.
Most recent transaction: a grant/award of 2387 shares of BIO-TECHNE Corp ($TECH) on March 02, 2026.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| March 2, 2026 | BIO-TECHNE Corp | $TECH | Crouse Steven C. | President - Diag & Spatial Bi | A | Performance Restricted Stock Units | 2387 | $0.00 | 2,387.0000 | 156,999,000 | 9999.99% | 0.00% |
| March 2, 2026 | BIO-TECHNE Corp | $TECH | Crouse Steven C. | President - Diag & Spatial Bi | A | Restricted Stock Units | 735 | $0.00 | 15,768.0000 | 156,999,000 | 4.89% | 0.00% |
| March 2, 2026 | BIO-TECHNE Corp | $TECH | Crouse Steven C. | President - Diag & Spatial Bi | A | Stock Option (right to buy) | 1911 | $0.00 | 111,053.0000 | 156,999,000 | 1.75% | 0.00% |
| June 17, 2025 | OmniAb, Inc. | $OABI | Crouse Steven C. | Director | A | Restricted Stock Units | 20000 | $0.00 | 60,000.0000 | 122,134,941 | 50.00% | 0.02% |
| June 17, 2025 | OmniAb, Inc. | $OABI | Crouse Steven C. | Director | A | Stock Option (right to buy) | 40000 | $0.00 | 40,000.0000 | 122,134,941 | 9999.99% | 0.03% |
| April 21, 2025 | OmniAb, Inc. | $OABI | Crouse Steven C. | Director | A | Restricted Stock Units | 40000 | $0.00 | 40,000.0000 | 122,134,941 | 9999.99% | 0.03% |
| April 21, 2025 | OmniAb, Inc. | $OABI | Crouse Steven C. | Director | A | Stock Option (right to buy) | 80000 | $0.00 | 80,000.0000 | 122,134,941 | 9999.99% | 0.07% |